Expert Video - Is remission the same in younger or older patients with AML?

Acute myeloid leukemia (AML) expert Dr. Barry Skikne discusses the differences in AML remission in younger and older patients with AML. In elderly patients, the duration of remission may be shorter than younger patients, although this may not always be the case. Older patients may not be able to have the most intensive treatment commonly used in induction and consolidation due to age, other health conditions, or for other reasons, or they may have an aggressive type of AML or other conditions that keep them from receiving intensive chemotherapy.

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.

Other Modules:

Understanding AML

Understanding AML-MRC and tAML

Understanding Erythropoiesis

Diagnosing AML, AML-MRC, and tAML

Treating AML

Maintenance and Continuous Treatment in AML

Animation - Treatment Failure and Relapse

Slide Show - Treatment Failure and Relapse

Expert Videos

1. What is treatment failure and relapse in AML?

2. Who is at risk of treatment failure and relapse in AML?

3. What happens in treatment failure in AML?

4. Why does AML treatment failure happen after chemo and/or radiation therapy?

5. How common is treatment failure and relapse in AML?

6. Can AML be cured?

7. How does targeted therapy impact AML remission?

8. Is remission the same in younger or older patients with AML?

9. How does AML classification help predict treatment outcomes?

10. Are clinical trials an option in treatment failure or relapse in AML?

Patient Videos

11. Ed's story: What has your AML diagnosis and treatment journey been so far?

12. Ed's story: What has helped you cope on a daily basis with your AML diagnosis?

13. Ed's story: What advice do you have for other patients on their journey with AML?

14. Paul's story: How was your AML diagnosed and what experiences have you had with treatment?

15. Paul's story: What advice do you have for other patients with AML?

16. Peggy's story: How did you find out you had AML?

17. Peggy's story: How did you first cope with your diagnosis of AML?

18. Peggy's story: What advice do you have for other AML patients managing treatment side effects?

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.